BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$615M |
| 2 |
State Street SPDR S&P Retail ETF
XRT
|
+$231M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$229M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$186M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$620M |
| 3 |
Tesla
TSLA
|
+$594M |
| 4 |
Apple
AAPL
|
+$541M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.24% |
| 2 | Financials | 6.85% |
| 3 | Healthcare | 5.31% |
| 4 | Consumer Discretionary | 4.97% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KZR
3301
DELISTED
Kezar Life Sciences
KZR
| $65.1K | ﹤0.01% |
754
+437
| +138% | +$28.9K |
|
3302
iBio
IBIO
$70M
| $64.9K | ﹤0.01% |
122
+61
| +100% | +$38K |
|
3303
Kiniksa Pharmaceuticals
KNSA
$6.06B
| $64.2K | ﹤0.01% |
5,633
+4,559
| +424% | +$59.4K |
|
|
BDSI
3304
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $63.8K | ﹤0.01% |
17,678
+14,619
| +478% | +$55.1K |
|
3305
Allient
ALNT
$1.87B
| $63.4K | ﹤0.01% |
2,028
+1,636
| +417% | +$53.5K |
|
|
KALV
3306
DELISTED
KalVista Pharmaceuticals
KALV
| $62.8K | ﹤0.01% |
3,599
+2,831
| +369% | +$57.4K |
|
|
MCBC
3307
DELISTED
Macatawa Bank Corp
MCBC
| $62.7K | ﹤0.01% |
7,809
+4,411
| +130% | +$36.1K |
|
|
SURF
3308
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $62.2K | ﹤0.01% |
8,218
+4,715
| +135% | +$30.2K |
|
3309
Limoneira
LMNR
$253M
| $62K | ﹤0.01% |
3,835
+3,100
| +422% | +$52.2K |
|
3310
Cytosorbents Corp
CTSO
$23.5M
| $61.7K | ﹤0.01% |
7,595
+6,120
| +415% | +$49.7K |
|
3311
Tenaris
TS
$26.6B
| $61.4K | ﹤0.01% |
2,909
+100
| +4% | +$2.03K |
|
3312
TotalEnergies
TTE
$193B
| $61.2K | ﹤0.01% |
1,276
+847
| +197% | +$37.6K |
|
3313
Donegal Group Class A
DGICA
$695M
| $61.1K | ﹤0.01% |
4,219
+2,106
| +100% | +$31.7K |
|
3314
Concrete Pumping Holdings
BBCP
$480M
| $61K | ﹤0.01% |
7,142
+3,417
| +92% | +$28.7K |
|
3315
Invesco DB Commodity Index Tracking Fund
DBC
$1.71B
| $61K | ﹤0.01% |
3,022
-1,756
| -37% | -$33.7K |
|
3316
BeyondSpring
BYSI
$37.4M
| $60.8K | ﹤0.01% |
3,857
+3,076
| +394% | +$55.3K |
|
3317
Nature's Sunshine
NATR
$274M
| $60.7K | ﹤0.01% |
4,140
+870
| +27% | +$14.6K |
|
|
PSTL
3318
Postal Realty Trust
PSTL
$703M
| $60.5K | ﹤0.01% |
3,247
+1,661
| +105% | +$31.8K |
|
3319
Red River Bancshares
RRBI
$681M
| $60.1K | ﹤0.01% |
1,206
+634
| +111% | +$32K |
|
3320
SoundThinking
SSTI
$107M
| $59.9K | ﹤0.01% |
1,648
+1,300
| +374% | +$54.6K |
|
3321
UroGen Pharma
URGN
$2.37B
| $59.9K | ﹤0.01% |
3,559
+2,785
| +360% | +$44.1K |
|
3322
XBiotech
XBIT
$72.6M
| $59.7K | ﹤0.01% |
4,610
+1,787
| +63% | +$28.5K |
|
|
MSON
3323
DELISTED
Misonix Inc
MSON
| $59.4K | ﹤0.01% |
2,348
+1,840
| +362% | +$45.5K |
|
3324
Preformed Line Products
PLPC
$2.26B
| $59.4K | ﹤0.01% |
913
+329
| +56% | +$23.2K |
|
3325
Flexsteel Industries
FLXS
$302M
| $59.2K | ﹤0.01% |
1,918
+988
| +106% | +$35.2K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2021 Portfolio in Review
As of Q3 2021, BNP Paribas Financial Markets held 4,161 positions worth $70.6B, down 6.6% from $75.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.5B in Q3 2021, closing 150 positions and reducing 1,194 holdings. Its most notable exit was GE Aerospace, an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares 10+ Year Investment Grade Corporate Bond ETF worth $5.86M.
- BNP Paribas Financial Markets's largest Q3 2021 buy was iShares 10+ Year Investment Grade Corporate Bond ETF: 84,600 shares worth $5.86M.
- BNP Paribas Financial Markets added most to iShares Russell 2000 ETF in Q3 2021, an estimated $615M increase.
- BNP Paribas Financial Markets's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.24B.
- BNP Paribas Financial Markets fully exited GE Aerospace in Q3 2021, selling an estimated $147M.
- BNP Paribas Financial Markets's ten largest holdings make up 14% of its $70.6B portfolio in Q3 2021.
- BNP Paribas Financial Markets opened 102 new positions and closed 150 in Q3 2021.
- BNP Paribas Financial Markets's portfolio value fell 6.6% quarter-over-quarter to $70.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2021, filed 12 Nov 2021.